| Revenue growth | +20% YoY; ₹15,600 Mn in Q2FY27 |
|---|---|
| Margins | Gross margin 64.4%, -134 bps YoY; EBITDA margin 21.6%, +19 bps YoY |
| Demand visibility | Strong filings momentum; 26 ANDAs pending; US TAM ~$35Bn |
| Management confidence | Constructive; cost pressures to persist, passed to customers with lag |
Growth
Revenue +20% YoY: FD +18%, API +23%, PFI +20%, CDMO +77%. Europe +65%, North America +14%. PAT +39% YoY.
Outlook
No explicit numeric FY27 guidance. ~₹20,000 Mn organic capex over 3–4 years; 3 potential sole first-to-file ANDAs filed.
Risks
Gross margin -134 bps YoY to 64.4% on West Asia input costs. Peptide CDMO EBITDA loss ₹152 Mn. Gagillapur EIR awaited.
Investor Presentation filed with NSE, NSE: GRANULES. Summary written with AI assistance from the document.
Granules India Ltd: key numbers
- Share price
- ₹821.95
- Market cap
- ₹20,368 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 30.8×Sector 45.9×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Results Update
Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY, and PAT of INR 1,818 Mn, up 39%. The company also cited a net cash position and a US FDA audit at its Gagillapur site.
Granules India Q2 FY27 Results: Net Profit ₹181.8 Cr, Up 39.2% YoY
Granules India Ltd reported revenue from operations of ₹1,560 Cr (+20.3% YoY) and net profit of ₹181.8 Cr (+39.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹181.8 Cr · +39.2% YoY
Granules India Business Update
Granules' Gagillapur facility received eleven USFDA observations with no impact on product supply. The inspection was the first since a February 2025 Warning Letter.
Granules India Convertible Warrants
Chigurupati family promoters disclosed acquiring 2,49,82,906 warrants via preferential allotment on 23 February 2026. Warrants priced at ₹585 each lift diluted promoter-group holding to 43.69%.
- Value
- ₹1,462 Cr
Granules India Convertible Warrants
Promoter group members Uma Devi, Priyanka, Pragnya and Harsha were allotted 2,49,82,906 Granules India shares on warrant conversion. The balance payment totals about ₹1,096.13 crore.
- Value
- ₹1,096 Cr
Granules India Promoter Selling
Promoter Dr Krishna Prasad Chigurupati filed a revised disclosure of selling 1,72,00,000 Granules India shares on 11 September 2026. Promoter group voting stake falls from 38.02% to 31.08%.